HR 2339
116th Congress
House
Health
Administrative law and regulatory procedures
Cancer
Cardiovascular and respiratory health
Child health
Civil actions and liability
Congressional oversight
Consumer affairs
Department of Health and Human Services
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Government information and archives
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Health facilities and institutions
Health information and medical records
Health programs administration and funding
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Introduced: April 18, 2019
Introduced by:
Pallone, Frank
Democratic
· New Jersey
See on congress.gov
Everywhere this bill has been
26 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 2, 2020
Received in the Senate and Read twice and referred to the Committee on Finance.
Feb 28, 2020
Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H1286-1287)
Feb 28, 2020
Motion to reconsider laid on the table Agreed to without objection.
Feb 28, 2020
On passage Passed by the Yeas and Nays: 213 - 195 (Roll no. 78). (text: CR H1257-1262)
Feb 28, 2020
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 213 - 195 (Roll no. 78).
Feb 28, 2020
On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 220 (Roll no. 77).
Feb 28, 2020
The previous question on the motion to recommit with instructions was ordered without objection.
Feb 28, 2020
Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to insert a new title at the end of the bill, "Born-Alive Abortion Survivors Protection."
Feb 28, 2020
Considered as unfinished business. (consideration: CR H1286-1289)
Feb 28, 2020
POSTPONED PROCEEDINGS - Pursuant to clause 1(c) of Rule XIX, further proceedings on H.R. 2339 were postponed.
Feb 28, 2020
The previous question was ordered pursuant to the rule.
Feb 28, 2020
DEBATE - The House proceeded with 90 minutes of debate on H.R. 2339.
Feb 28, 2020
Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
Feb 28, 2020
Considered under the provisions of rule H. Res. 866. (consideration: CR H1257-1286)
Feb 27, 2020
Rule H. Res. 866 passed House.
Feb 26, 2020
Rules Committee Resolution H. Res. 866 Reported to House. Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
Feb 21, 2020
Placed on the Union Calendar, Calendar No. 324.
Feb 21, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-402.
Nov 19, 2019
Ordered to be Reported (Amended) by the Yeas and Nays: 28 - 24.
Nov 19, 2019
Committee Consideration and Mark-up Session Held.
Nov 13, 2019
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Nov 13, 2019
Subcommittee Consideration and Mark-up Session Held.
Oct 16, 2019
Subcommittee Hearings Held.
Apr 19, 2019
Referred to the Subcommittee on Health.
Apr 18, 2019
Referred to the House Committee on Energy and Commerce.
Apr 18, 2019
Introduced in House
Votes taken on this bill
2
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Feb 28, 2020 | House · vote #78 | On Passage | Passed | 213–195 | See who voted → |
| Feb 28, 2020 | House · vote #77 | On Motion to Recommit with Instructions | Failed | 187–220 | See who voted → |
Plain-English summary
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).
Among other requirements, the bill
- requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
- requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
- generally prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
- prohibits flavors other than tobacco in a tobacco product;
- prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
- increases the user fees that the FDA collects from manufacturers and importers;
- directs the FDA to regulate products containing nicotine not made or derived from tobacco plants (including nicotine from chemical synthesis, recombinant genetic technology, or extraction from non-tobacco plants);
- imposes an excise tax on nicotine that has been extracted, concentrated, or synthesized;
- provides funding through FY2025 to support public education regarding tobacco regulation, public awareness regarding the harms associated with tobacco use, outreach to medically underserved communities regarding tobacco-use prevention and cessation, research grants related to tobacco-use prevention and cessation, and grants to health centers for tobacco-use cessation treatment;
- establishes and provides funding through FY2025 for a demonstration grant program to develop strategies for smoking cessation (including of the use of menthol-flavored tobacco products) in medically underserved communities;
- beginning in 2024, waives coinsurance under Medicare for colorectal-cancer screening tests;
- specifies that a health insurance plan may still be treated, for certain tax-deduction purposes, as a high-deductible plan even if it does not have a deductible for certain inhalers or nebulizers;
- exempts certain cigars from premarket review requirements;
- increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
- requires the Government Accountability Office to study e-cigarettes.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Finance.
Committees of jurisdiction
3